CIK 1778253
Ikarian Capital, LLC
Institutional 13F holdings & portfolio
Holdings
148
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 101–148 of 148
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| HELP | CYBIN INC | 132K | $1M+ | SH |
| STIM | NEURONETICS INC | 701K | $500K+ | SH |
| SLDB | SOLID BIOSCIENCES INC | 160K | $500K+ | SH |
| LABD | DIREXION SHS ETF TR | 41K | $500K+ | SH |
| IOBT | IO BIOTECH INC | 1.4M | $500K+ | SH |
| DFTX | MIND MEDICINE MINDMED INC | 59K | $500K+ | SH |
| TRAW | TRAWS PHARMA INC | 678K | $500K+ | SH |
| PALI | PALISADE BIO INC | 275K | $500K+ | SH |
| KZR | KEZAR LIFE SCIENCES INC | 102K | $500K+ | SH |
| KALV | KALVISTA PHARMACEUTICALS INC | 35K | $500K+ | SH |
| AVTX | AVALO THERAPEUTICS INC | 31K | $500K+ | SH |
| ABOS | ACUMEN PHARMACEUTICALS INC | 254K | $500K+ | SH |
| SGMO | SANGAMO THERAPEUTICS INC | 1.2M | $500K+ | SH |
| IMTX | IMMATICS N.V | 49K | $500K+ | SH |
| EQ | EQUILLIUM INC | 304K | $100K–$500K | SH |
| OVID | OVID THERAPEUTICS INC | 248K | $100K–$500K | SH |
| IMUX | IMMUNIC INC | 675K | $100K–$500K | SH |
| EVAX | EVAXION AS | 75K | $100K–$500K | SH |
| VTGN | VISTAGEN THERAPEUTICS INC | 519K | $100K–$500K | SH |
| VKTX | VIKING THERAPEUTICS INC | 10K | $100K–$500K | SH |
| GPCR | STRUCTURE THERAPEUTICS INC | 5K | $100K–$500K | SH |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 13K | $100K–$500K | SH |
| VERU | VERU INC | 134K | $100K–$500K | SH |
| CNSP | CNS PHARMACEUTICALS INC | 46K | $100K–$500K | SH |
| SNSE | SENSEI BIOTHERAPEUTICS INC | 21K | $100K–$500K | SH |
| NYXH | NYXOAH S A | 47K | $100K–$500K | SH |
| VYGR | VOYAGER THERAPEUTICS INC | 53K | $100K–$500K | SH |
| LXRX | LEXICON PHARMACEUTICALS INC | 165K | $100K–$500K | SH |
| NEUP | NEUPHORIA THERAPEUTICS INC | 47K | $100K–$500K | SH |
| GCTK | GLUCOTRACK INC | 46K | $100K–$500K | SH |
| VYNE | VYNE THERAPEUTICS INC | 265K | $100K–$500K | SH |
| RNAC | CARTESIAN THERAPEUTICS INC | 21K | $100K–$500K | SH |
| SHPH | SHUTTLE PHARMACTCLS HLDGS IN | 69K | $100K–$500K | SH |
| MGNX | MACROGENICS INC | 75K | $100K–$500K | SH |
| PMVP | PMV PHARMACEUTICALS INC | 89K | $100K–$500K | SH |
| — | HYPERLIQUID STRATEGIES INC | 30K | $100K–$500K | SH |
| MGRX | MANGOCEUTICALS INC | 138K | $100K–$500K | SH |
| CMMB | CHEMOMAB THERAPEUTICS LTD | 52K | $50K–$100K | SH |
| LYRA | LYRA THERAPEUTICS INC | 21K | $50K–$100K | SH |
| JSPR | JASPER THERAPEUTICS INC | 24K | $15K–$50K | SH |
| AEMD | AETHLON MED INC | 14K | $15K–$50K | SH |
| RZLT | REZOLUTE INC | 16K | $15K–$50K | SH |
| PHGE | BIOMX INC | 19K | $15K–$50K | SH |
| AIRS | AIRSCULPT TECHNOLOGIES INC | 16K | $15K–$50K | SH |
| TOVX | THERIVA BIOLOGICS INC | 112K | $15K–$50K | SH |
| SYBX | SYNLOGIC INC | 20K | $15K–$50K | SH |
| ANEB | ANEBULO PHARMACEUTICALS INC | 18K | $15K–$50K | SH |
| AMIX | AUTONOMIX MED INC | 19K | $1K–$15K | SH |